You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

2,4-thiazolidinedione

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

A Pan-European Post-Authorisation Safety Study: Risk of

Not yet recruiting
  • Pancreatic Cancer
  • Exenatide
  • Non-GLP-1 RA based glucose lowering drugs
  • (no location specified)
Dec 21, 2022

Type 2 Diabetes Trial in Exeter (Sitagliptin - DPP4i, Canagliflozin - SGLT2i, Pioglitazone - TZD)

Completed
  • Type 2 Diabetes
  • Sitagliptin - DPP4i
  • +2 more
  • Exeter, United Kingdom
    Exeter Clinical Research Facility
Mar 30, 2021

Type 2 Diabetes Trial in Seoul (TZD group, SGLT-2 group)

Completed
  • Type 2 Diabetes Mellitus
  • TZD group
  • SGLT-2 group
  • Seoul, Korea, Republic of
    Division of Endocrinology and Metabolism, Department of Internal
May 3, 2021

Diabetes, Diabetes, Type 2, Glucose Metabolism Disorders Trial in Japan (Dulaglutide, Biguanide (BG), Sulfonylurea (SU))

Active, not recruiting
  • Diabetes Mellitus
  • +6 more
  • Nagoya-shi, Aichi, Japan
  • +43 more
Jan 16, 2023

Diabetes Type 2 With Proteinuria, Diabetes, Type 2, Diabetes Trial (drug, device, diagnostic test, behavioral)

Not yet recruiting
  • Diabetes Mellitus Type 2 With Proteinuria
  • +12 more
  • Empagliflozin 10 MG
  • +6 more
  • (no location specified)
Oct 17, 2023

Advanced Solid Tumor Trial in Shanghai (B4T2-001 autologous CAR-T)

Recruiting
  • Advanced Solid Tumor
  • B4T2-001 autologous CAR-T
  • Shanghai, China/Shanghai, China
  • +1 more
Oct 3, 2023

Natural History Study for Charcot Marie Tooth Disease

Recruiting
  • Charcot-Marie-Tooth Disease
  • +47 more
    • New York, New York
      Hereditary Neuropathy Foundation
    Jun 12, 2023

    Smallpox, Monkeypox, Cowpox Trial in Novosibirsk (NIOCH-14, 200 mg capsule: 1 capsule (200 mg) of NIOCH-14 once orally,

    Completed
    • Smallpox
    • +3 more
    • NIOCH-14, 200 mg capsule: 1 capsule (200 mg) of NIOCH-14 once orally
    • +5 more
    • Novosibirsk, Koltsovo, Novosibirsk Region, Russian Federation
      Federal State Budgetary Healthcare Institution - Medical and San
    Jul 27, 2023

    Ovarian Cancer Trial (Autologous genetically modified ADP-A2M4CD8 cells, Autologous genetically modified ADP-A2M4CD8 cells in

    Not yet recruiting
    • Ovarian Cancer
    • Autologous genetically modified ADP-A2M4CD8 cells
    • Autologous genetically modified ADP-A2M4CD8 cells in combination with Nivolumab
    • (no location specified)
    Jan 31, 2023

    Type 2 Diabetes Trial (4.8 g/m^2/day NaPB, 4.8 g/m^2/day )

    Not yet recruiting
    • Type 2 Diabetes
    • 4.8 g/m^2/day NaPB
    • 4.8 g/m^2/day placebo
    • (no location specified)
    Apr 26, 2023

    Advanced HR-positive and HER2-negative Breast Cancer; CDK4/6 Inhibitor Treatment Failed Trial in Hangzhou (dalpiciclib;

    Recruiting
    • Advanced HR-positive and HER2-negative Breast Cancer; CDK4/6 Inhibitor Treatment Failed
    • dalpiciclib; fluvestrant; compound gossypol acetate tablets
    • Hangzhou, Zhejiang, China
      zhejiangCH
    Nov 9, 2023

    Prostate Cancer Trial ([99mTc]Tc-PSMA-T4)

    Not yet recruiting
    • Prostate Cancer
    • [99mTc]Tc-PSMA-T4
    • (no location specified)
    Apr 26, 2023

    CDK4/6 Inhibitors Combined With Endocrine Therapy and Subsequent

    Not yet recruiting
    • Breast Cancer
    • +3 more
    • Different treatment regimens following progression on CDK4/6 inhibitors.
    • (no location specified)
    Sep 5, 2023

    Malignant Solid Tumor Trial in Philadelphia (Biopsy, Biospecimen Collection, Echocardiography)

    Active, not recruiting
    • Malignant Solid Neoplasm
    • Biopsy
    • +5 more
    • Philadelphia, Pennsylvania
      ECOG-ACRIN Cancer Research Group
    Nov 15, 2023

    Type 2 Diabetes Trial in Lubbock (L-citrulline, Placebo)

    Recruiting
    • Type 2 Diabetes
    • L-citrulline
    • Placebo
    • Lubbock, Texas
      TTU Kinesiology and Sport Management Building
    Aug 24, 2023

    Laparoscopy Trial in Basel (Gastric bypass surgery with 2D 4K laparoscopic imaging, Gastric bypass surgery with 3D HD

    Not yet recruiting
    • Laparoscopy
    • Gastric bypass surgery with 2D 4K laparoscopic imaging
    • Gastric bypass surgery with 3D HD laparoscopic imaging
    • Basel, Switzerland
      Clarunis University Center for Gastrointestinal and Liver Diseas
    May 30, 2023

    Solid Malignancy, Lymphoma Trial in New York ([18F] 4-L-Fluoroglutamine (2S,4R))

    Recruiting
    • Solid Malignancy
    • Lymphoma
    • [18F] 4-L-Fluoroglutamine (2S,4R)
    • New York, New York
      Memorial Sloan Kettering Cancer Center
    Nov 28, 2022

    Multiple Myeloma in Relapse, Multiple Myeloma, Multiple Myeloma, Refractory Trial (Pomalidomide 4 mg every day in cycle 1,

    Not yet recruiting
    • Multiple Myeloma in Relapse
    • +2 more
    • Pomalidomide 4 mg every day in cycle 1
    • +4 more
    • (no location specified)
    Nov 16, 2022

    Nasal Decolonization of Staphylococcus Aureus Trial in Uppsala (Vehicle gel, 4 + 4 applications or 4 + 2 applications, LTX-109

    Completed
    • Nasal Decolonization of Staphylococcus Aureus
    • Vehicle gel, 4 + 4 applications or 4 + 2 applications
    • +2 more
    • Uppsala, Sweden
      ClinSmart Sweden AB
    May 25, 2023

    Uric Acid Kidney Stone Disease Trial in Dallas (Pioglitazone, Placebo)

    Recruiting
    • Uric Acid Kidney Stone Disease
    • Dallas, Texas
      UT Southwestern Medical Center - Center for Mineral Metabolism
    Dec 20, 2021

    Myelodysplastic Syndrome, Recurrent Myelodysplastic Syndrome, Refractory Myelodysplastic Syndrome Trial in Philadelphia

    Recruiting
    • Myelodysplastic Syndrome
    • +2 more
    • Navitoclax
    • +6 more
    • Philadelphia, Pennsylvania
      Sidney Kimmel Cancer Center at Thomas Jefferson University
    Feb 2, 2023

    Acute Myeloid Leukemia, Recurrent Acute Myeloid Leukemia, Refractory Acute Myeloid Leukemia Trial in Philadelphia (STAT

    Active, not recruiting
    • Acute Myeloid Leukemia
    • +2 more
    • STAT Inhibitor OPB-111077
    • +3 more
    • Philadelphia, Pennsylvania
      Sidney Kimmel Cancer Center at Thomas Jefferson University
    Dec 20, 2022

    Bladder Cancer Trial (Multi4)

    Not yet recruiting
    • Bladder Cancer
    • Multi4
    • (no location specified)
    Nov 14, 2023

    Bietti's Crystalline Dystrophy Trial in Beijing (ZVS101e)

    Recruiting
    • Bietti's Crystalline Dystrophy
    • Beijing, Beijing, China
      Peking University Third Hospital
    Feb 2, 2023

    Recurrent Acute Myeloid Leukemia, Refractory Acute Myeloid Leukemia Trial in Philadelphia (Palbociclib, Tazemetostat,

    Not yet recruiting
    • Recurrent Acute Myeloid Leukemia
    • Refractory Acute Myeloid Leukemia
    • Philadelphia, Pennsylvania
      Thomas Jefferson University Hospital
    Jan 13, 2023